CEO and President L Daniel Browne sold $251K of Revance Therapeutics, Inc.

Sold$251,250

$20.94Price

12,000Shares

−6%Stake

What RVNC did after the filing

Prices for RVNC after this filing aren't in yet.

Traded Wed, Dec 28. Filed Fri, Dec 30, 1:38 PM ET, during the session. Not investment advice.